Literature DB >> 10360636

Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia.

J D Belcher1, P H Marker, P Geiger, A W Girotti, M H Steinberg, R P Hebbel, G M Vercellotti.   

Abstract

Patients with sickle-cell anemia exhibit pro-oxidative metabolic perturbations. We hypothesize that because of chronic oxidative stress, plasma low-density lipoprotein (LDL) from patients with sickle-cell anemia is more susceptible to oxidation. To test this hypothesis, LDL susceptibility to copper-mediated oxidation was measured in 24 patients with sickle-cell anemia and 48 control subjects. Sickle-cell LDL was more susceptible to oxidation than control LDL, measured by a 22% shorter mean lag time between LDL exposure to CuSO4 and conjugated diene formation (97 vs 124 minutes; P = .023). LDL vitamin E, iron, heme, and cholesterol ester hydroperoxide (CEOOH) levels were also measured. LDL vitamin E levels were significantly lower in patients with sickle-cell anemia compared with control subjects (1.8 vs 2.9 mol/mol LDL; P = .025), but there was no correlation with lag time. Pro-oxidant heme and iron levels were the same in sickle-cell and control LDL. LDL CEOOHs were not significantly different in sickle and control LDL (3.1 vs 1.2 mmol/mol of LDL unesterified cholesterol, P = .15), but LDL CEOOH levels were inversely correlated with lag times in patients with sickle-cell anemia (r2 = 0.38; P = .018). The cytotoxicity of partially oxidized LDL to porcine aortic endothelial cells was inversely correlated with lag times (r2 = 0.48; P = .001). These preliminary data suggest that increased LDL susceptibility to oxidation could be a marker of oxidant stress and vasculopathy in patients with sickle-cell anemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360636     DOI: 10.1016/s0022-2143(99)90191-9

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  17 in total

Review 1.  The multifaceted role of ischemia/reperfusion in sickle cell anemia.

Authors:  Robert P Hebbel; John D Belcher; Gregory M Vercellotti
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 2.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.

Authors:  Suzana Zorca; Lita Freeman; Mariana Hildesheim; Darlene Allen; Alan T Remaley; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

Review 4.  The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.

Authors:  Edward Gomperts; John D Belcher; Leo E Otterbein; Thomas D Coates; John Wood; Brett E Skolnick; Howard Levy; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2017-04-29       Impact factor: 10.047

Review 5.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

6.  A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.

Authors:  Robert P Hebbel; Greg Vercellotti; Karl A Nath
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2009-12

7.  Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.

Authors:  Ayla Yalamanoglu; Jeremy W Deuel; Ryan C Hunt; Jin Hyen Baek; Kathryn Hassell; Katie Redinius; David C Irwin; Dominik J Schaer; Paul W Buehler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

8.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

9.  The Role of Nutrition in Sickle Cell Disease.

Authors:  H I Hyacinth; B E Gee; J M Hibbert
Journal:  Nutr Metab Insights       Date:  2010-01-01

10.  Pathophisiology of sickle cell disease and new drugs for the treatment.

Authors:  Lucia De Franceschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-20       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.